Current Trends in Pharmacy and Pharmaceutical Chemistry

Online ISSN: 2582-5062

Current Trends in Pharmacy and Pharmaceutical Chemistry is the official Journal of Ateos Foundation of Science Education and Research, hosted and Managed IP Innovative Publications Pvt. Ltd, New Delhi, India. Current Trends in Pharmacy and Pharmaceutical Chemistry is an open access, peer-reviewed quarterly international journal publishing since 2019 and is published under auspices of the Ateos Foundation of Science Education and Research. It aims to uplift researchers, scholars, academicians, and professionals in all academic and scientific disciplines. more...

  • Article highlights
  • Article tables
  • Article images

Article statistics

Viewed: 552

PDF Downloaded: 388


Get Permission Pratap Singh and Sharma: Arsenic exposure and its toxicity


Introduction

Arsenic is a naturally occurring metalloid, which means it has both metal and non-metal properties; it is commonly referred to as a heavy metal. Arsenic comes in a variety of forms known as allotropes. It is found in more than 245 minerals and is the twentieth most abundant element in the earth's crust. Human health is endangered by the inorganic forms, which mostly consist of arsenite (AsIII) and arsenate (As V) chemicals. Grey arsenic is the most common and widely used of the three arsenic allotropes, which include metallic grey, yellow, and black arsenic. Arsenic is a common element that may be found in the earth's crust, saltwater, and the human body. It ranks 20th in abundance in the earth's crust, 14th in seawater, and 12th in the human body. It makes up around five hundredths of one percent (0.00005 percent) of the earth's crust. It is found in nature in the form of metalloids or chemical compounds, and is primarily found in inorganic forms. It is divided into two species: arsenate and arsenite. Arsenite is far more flammable, soluble, and mobile than As (V).1

Occurrence

Arsenic is found in the range of 1.5–3 mg kg1 in the environment. Arsenic is found in the environment as a result of both natural and man made sources. Arsenic is a naturally occurring element present in the earth's crust, soil and sediment, water, air, and plants and animals. Some agricultural and industrial sources might also discharge it into the environment. Arsenite concentrations in drinking water range from 0.01 to 3.7 mg/l (1.3–49 M). According to anthropogenic sources, arsenic can be obtained through man-made sources in a variety of products, with China, the Soviet Union, France, Mexico, Germany, Peru, Namibia, Sweden, and the United States accounting for about 90% of global production. According to WHO recommendations, arsenic has a safety limit of 10 g/l and a maximum acceptable value of 50 g/l in drinking water.2

Figure 1

Areas with arsenic contamination2

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/5e7e62e0-3486-4de4-a243-c530e2b9a4b4image1.png

Uses of arsenic

Insecticides and pesticides containing arsenic were widely utilised over the world. Sodium arsenite and other inorganic arsenic compounds have traditionally been employed as non-selective soil sterilants to destroy weeds. Arsenic is also employed as desiccants and wood preservatives, in addition to insecticides and herbicides.3, 4 Arsenic compounds are also utilised to treat a variety of ailments. Arsenic has a long history of being used by peasants for skin cleanliness, suppleness, and other cosmetic advantages. It was also used to help those with breathing problems.5, 6 Fowler’s solution (potassium arsenite), Donovan’s solution (arsenic and mercuric iodides), Asiatic pills (arsenic trioxide and black pepper), de Valagin’s solution (liquor arsenii chloridi), sodium cacodylate, arsphenamine (Salvarsan), neoarsphenamine, oxophenarsine hydrochloride (Mapharsen), arsthinol (Balarsen), acetarsone, tryparsamide and carbarsone are the most common medicinal preparations containing arsenic. References.7, 8 Despite the fact that it is only used for a few medical purposes, Arsenic is a well-known toxin that has a number of negative effects on physical and mental health.9

Exposure

Arsenic is a potent toxicant, and its abundance in many natural forms makes it quite frequent to be exposed to it. As a result, the opportunity for arsenic toxicity research is immense. Arsenic is typically absorbed by eating and inhalation. Another secondary way of exposure is through the skin, or dermal exposure. Humans can be exposed to arsenic through ingesting arsenic-laced food or drinking arsenic-laced water. Inhalation exposure can also occur through emissions from arsenic-containing fossil fuels, cotton gins, glass manufacturing operations, pesticide production facilities, smelters, and cigarette smoke. When working with preserved wood that has been treated with arsenic compounds, it is possible to get arsenic poisoning through the skin.10

Arsenic toxicity

Arsenic toxicity in the body depends on its chemical forms and oxidative stress as well as the physical state, absorption rate into the cells and its elimination rate, the nature of chemical substituents in toxic compounds, etc. A number of studies have shown that when compared among the inorganic arsenic compounds and organic arsenic compounds, the inorganic ones are more toxic and the inorganic AsIII is more toxic than inorganic AsV.11 The toxicity order of arsenic compounds may be depicted as Arsines > iAsIII > arsenoxides(org AsIII) > iAsV > arsonium compounds > As12, 13

Figure 2

Effect of arsenic on various body parts13

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/5e7e62e0-3486-4de4-a243-c530e2b9a4b4image2.png

Overexposure to arsenic leads to a number of adverse physiological effects which include respiratory effects (laryngitis, tracheae bronchitis, rhinitis, pharyngitis, shortness of breath, chest sounds (crepitation and/or rhonchi), nasal congestion and perforation of the nasal septum,14 Cardiovascular effects (Raynaud’s disease, myocardial infarction, myocardial depolarization, cardiac arrhythmias, thickening of blood vessels and their occlusion and BFD, Haematological effects (Anaemia and leukopenia), gastrointestinal effects (Sub acute arsenic toxicity- mouth and throat, heartburn, nausea, abdominal pains and cramps, and moderate diarrhoea; Chronic toxicity- mild esophagitis, gastritis, or colitis with respective upper and lower abdominal discomfort Anorexia, mal-absorption),14 Hepatic effects, Renal effects (Proximal tubule degeneration, haematuria and proteinuria,15 oliguria, shock and dehydration with a real risk of renal failure,16 cortical necrosis,17 and cancer.18

Table 1

Arsenic exposure and adverse health effects: A review of recent findings from arsenic and health studies in Matlab, Bangladesh (2011)18

Studies

Study Design

Characteristics Participants

Arsenic Measurements

Main Findings

Rahman et al.

Cross-sectional

All population aged 4 yr or older (166,934)

Water arsenic

Prevalence of skin lesion

Rahman et al.

Case-referent

All skin lesion cases (504) and randomly selected 1,830 individuals

Water arsenic

Skin lesion, dose-response trend, gender difference in risk

Jakariya et al.

Cross-sectional

Tube-well screening

Water arsenic

Public health importance

Hore et al.

Cross-sectional

All population aged 4 yr or older (166,934)

Water arsenic

Validity of detection skin lesion cases

Rahman et al.

Historical cohort

All pregnancy outcome during 1991-2000 (29,134)

Water arsenic

Fetal loss and infant deaths

Lindberg, Rahman et al.

Cross-sectional

Randomly selected 1,830 individuals

Urinary arsenic

Influence of factors on exposure and metabolism

Lindberg, Ekstrom et al.

Cross-sectional

Randomly selected 526 individuals

Urinary arsenic

Interaction between gender and arsenic metabolism

Sohel et al.

Historical cohort

All adult population aged 15 yr or older on 1 January, 1991 (115,903)

Water arsenic

Excessive mortality risk for cancer, cardiovascular, all infections and non-accidental deaths

Toxicity mechanism

Arsenic exerts its toxic effects by inactivation of various enzymes that are responsible for a number of cellular pathways and DNA replication and repair. Various mechanisms that relate to arsenic toxicity are oxidative stress, modification of cellular signalling, apoptosis, epigenetic modifications that results in abnormal gene expression, inhibition of DNA repair.19, 20, 21 Arsenite increases the generation of ROS, which enhances lipid peroxidation and cellular damage in both hepatic and renal tissue.22

Most laboratory animals appear to be substantially less susceptible to arsenic than humans. It has been reported that chronic oral exposure to inorganic arsenic causes neurological and haematological toxicity in humans but not in monkeys, dogs, and rats exposed to arsenite or arsenate at doses of 0.72 to 2.8 mg/kg/day.23

Arsenic induced oxidative stress increases the expression of HO1 and MAPK, which by regulating various transcription factors such as activator protein1 (AP1), activating transcription factor2 (ATF2), and Elk1 lead to renal toxicity.24 Acute renal dysfunction due to arsenic exposure is characterized by acute tubular necrosis and cast formation with increase in blood urea nitrogen and creatinine levels.25

The Millard County study reported an increased mortality from nephritis and prostate cancer. Guo et al. in 1997 analysed cancer registry data (1980–87) of tumours of the bladder and kidney in Taiwan and reported that high arsenic levels in drinking water from wells were associated with transitional cell carcinomas of the bladder, kidney, ureter and all urethral cancers in both males and females, and adenocarcinomas of the bladder in males. When As is administered alone it does not produce tumors in traditional animal models, but it can act as a carcinogen in animal models using fetal exposure paradigms because As crosses the placenta.26

As readily crosses the placenta, thus it may alter prenatal development. It is a well-known teratogen. In a human pregnancy case of arsenic trioxide poisoning it was documented that inorganic arsenic crosses human placenta with much ease and with extremely high levels in fetal liver, brain and kidney Lugo et al.27 A comparative toxicity study of arsenic, copper and chromium concluded that arsenic (Sodium arsenate 5mg As/kg ip) was not found to be fetotoxic or either effect fetal weight or maternal toxicity but the incidences of fetal abnormalities were higher.28

Respiratory effects

Effects of arsenic on the human respiratory system have been reported both from occupational exposure as well as from tube well water arsenic toxicity. Humans exposed to arsenic dust or fume inhalation are more opt to be encountered in mining and milling of ores, in industrial processing, such as smelting industry which often produces irritation of the mucous membrane, resulting in laryngitis, bronchitis, rhinitis and tracheobronchitis, causing stuffy nose, sore throat, hoarseness and chronic cough etc.29 Very high exposure to unprotected workers may manifest perforated nasal septum after 1-3 weeks of exposure,30 but such effects are minor or absent at exposure levels of 0.01-1 mg/m3. A fatal case of arsenic trioxide inhalation manifested widespread tracheobronchial mucosal and sub mucosal haemorrhages with mucosal sloughing, alveolar haemorrhages, and pulmonary edema. Chronic asthmatic bronchitis and asthma is a common complication of ground water arsenic toxicity.31

Effects on kidney

Kidney is a target organ for heavy metals. They accumulate in several segments of the nephron and cause profound alterations in morphology and function. Due to its secretory mechanisms, tubular proximal cells are often exposed to higher concentrations of toxic substances than those occurring in plasma or extracellular fluids. Arsenic gets accumulated in the kidney during its urinary elimination that affects the function of proximal convoluted tubules. In addition to these functions, kidney also plays a critical role in the bio transformation of toxic compounds and neutralize there toxic effect and change the chemical properties so that they become soluble in the aqueous media and easily excreted from the body several mechanisms to absorb and excrete toxicants. Exposures in utero and early post-natal development may be important triggers for disease susceptibility and cause severe impairment of organ function in later life (Yeonjin lee et al.,2012).32

Cardiovascular effects

It has been suggested by several epidemiological studies that chronic inhalation of arsenic trioxide can increase the risk of death in humans from cardiovascular disease.33, 34, 35 Long term inhalation of inorganic arsenic could injure the blood vessels or the heart. Zaldivar35 reported several cases of myocardial infarction and arterial thickening in children who consumed water containing about 0.6 mg/l arsenic. Arsenic ingestion through food or water may have serious effects on the human cardiovascular system. Both acute and chronic arsenic exposure cause altered myocardial depolarization and cardiac arrhythmias that may lead to heart failure.36, 37 Low level arsenic exposure by humans may also cause vascular system damage, a classical example of which is Blackfoot disease, which is endemic in an area of Taiwan where most drinking water contains 0.17 to 0.8 ppm arsenic,38, 39 corresponding to doses of about 0.01 to 0.5 mg As/kg/day. In ground water arsenicosis of West Bengal this ischaenice gangrene from vasenlitis are not seen probably due to less arsenic concentration circulating in blood stream.40

Renal effects

Like the liver, the kidneys will accumulate arsenic in the presence of repeated exposures. The kidneys are the major route of arsenic excretion, as well as major site of conversion of pentavalent arsenic into the more toxic and less soluble trivalent arsenic. Sites of arsenic damage in the kidney include capillaries, tubules, and glomeruli.41

Cellular mechanism

Arsenic induced toxicity is caused due to oxidative stress, altered cellular signaling cascade via altered expression and interaction of transcription factors to its target molecules and DNA binding sites, altered epigenetic patterns thus resulting in abnormal gene expression. Possible mechanisms of arsenic induced carcinogenicity include genotoxic and cytotoxic mechanisms. Arsenic disrupts the genomic integrity of the cell via a complex network of aberrant signaling cascades and dysregulated transcription factors induced by arsenic mediated ROS generation. Arsenic also affects the native DNA methylation and Histone acetylation patterns.42

Many studies to demonstrate the mechanism of arsenic toxicity have suggested that reactive oxygen species and reactive nitrogen species are generated during inorganic arsenic metabolism in living cells. Arsenic shows a rapid decline of mitochondrial membrane potential and induces morphologic changes in mitochondrial integrity. Mitochondrial alterations are considered to be primary sites where an uncontrolled random formation of superoxide anion radical occurs. Experimental results based on both in vivo and in vitro studies of arsenic‐exposed humans and animals suggest the possible involvement of increased formation of peroxyl radicals (ROO), superoxide anion radical (O2), singlet oxygen (O2), hydroxyl radical (OH), hydrogen peroxide (H­2O2), dimethylarsenic radical [(CH3)2As], blood nonprotein sulfydryls and/or oxidant‐induced DNA damage.42

Figure 3

Cellular effects of arsenic43

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/5e7e62e0-3486-4de4-a243-c530e2b9a4b4image3.png

In a study on HL-60 cells which were treated with varying concentration of arsenic trioxide (ATO) it was found that ATO-induced oxidative stress caused an increase in the expression level of pro-apoptotic proteins (Bax and cytochrome C) and reduced the expression level of anti-apoptotic protein (Bcl-2), in a dose-dependent manner. Densitometric analysis has shown that ATO-induced apoptotic proteins, cytchrome C and Bax expression significantly (p < 0.05) at 4 and 6 μg/ml ATO treated HL-60 cells lysate (2B). Whereas, anti-apoptotic protein, Bcl- increased 2 expression was significantly down regulated at 6 and 8 μg/ml ATO treatment cells lysate (2B). Inside the cytosol, cytochrome C stimulates a series of apoptotic signaling molecules along with variety of caspases (like caspase 9) and finally caspase3 which is main executioner of mitochondrial pathway of apoptosis.43

Figure 4

Arsenic induced genotoxicity43

https://s3-us-west-2.amazonaws.com/typeset-prod-media-server/5e7e62e0-3486-4de4-a243-c530e2b9a4b4image4.png

Toxicokinetics

Absorption

90% absorption of ingested arsenic takes place through the gastrointestinal tract, wherein the major site of absorption is the small intestine. This absorption takes place through an electrogenic process involving a proton (H+) gradient.44 The optimum pH required for the absorption of Arsenic is 5,45 though the pH in the small intestine is approximately 7.0 due to the presence of pancreatic bicarbonate secretions.46

Distribution

The bio availability of ingested inorganic arsenic varies depending on the matrix in which it is ingested (i.e. be it food, water, beverages or soil), the solubility of the arsenical compound itself and the presence of other food constituents and nutrients in the gastrointestinal tract. Tissue distributions of arsenic depend on blood perfusion, tissue volumes, diffusion coefficients, membrane characteristics, and tissue affinities.46

Metabolism & elimination

The absorbed arsenic undergoes methylation reaction in the liver. The methylation process is mediated by arsenic methyltransferase enzymes to form monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA).

DMA is the dominant metabolite according to many studies, while in human the urinary excretion consists under normal conditions, i.e. without excessive ingestion of inorganic arsenic—of about 20% inorganic arsenic, 20% MMA and 60% DMA.

Conclusion

Chronic exposure to arsenic from contaminated water may cause a variety of health problems. Arsenic promotes cardiovascular problems through increasing oxidative stress, up regulating pro inflammatory cytokines and inflammatory mediators, inactivating eNOS, and phosphorylating MLCK. The pathogenic events linked with arsenic-induced diabetes include decreased PPAR- expression, interference with ATP-dependent insulin secretion, altered glucocorticoid receptor-mediated transcription, and inhibition of PDK-1. Furthermore, oxidative stress, pyruvate decarboxylase inhibition, and acetyl cholinesterase appear to be important in arsenic-induced neurotoxicity. Furthermore, arsenic increases oxidative stress and apoptosis, causing nephrotoxicity and hepatotoxicity. Arsenic may also be carcinogenic because it causes oxidative DNA damage and chromosomal abnormalities, as well as interfering with cellular signalling networks. Targeting and modifying the aforementioned main pathogenic signalling systems could lead to new pharmaceutical approaches to treat arsenic-related diseases.

Source of Funding

None.

Conflict of Interest

None.

References

1 

K Jomova Arsenic: toxicity, oxidative stress and human diseaseJ Appl Toxicol20113129510710.1002/jat.1649

2 

International Programme on Chemical Safety WHO: Environmental Health Criteria 224-Arsenic. International Programme on Chemical Safety, Geneva2001https://apps.who.int/iris/handle/10665/42366

3 

B K Mandal K T Suzuki Arsenic round the world: a reviewTalanta200258120121

4 

Arsenic-EatersBoston Med Surg J185451189

5 

T Sollman A Manual of PharmacologyJ Am Pharm Assoc195737313110.1002/jps.3030370320

6 

A. Burger Medicinal Chemistry197061025

7 

R J Sullivan Administration Publication No. APTD 69-26196960https://www.govinfo.gov/content/pkg/FR-1990-06-25/pdf/FR-1990-06-25.pdf

8 

M N Bates H Allan C Smith H Rich Arsenic ingestion and internal cancers: a reviewAm J Epidemiol199213554627610.1093/oxfordjournals.aje.a116313

9 

United Nations Synthesis Report on Arsenic in Drinking Water2001https://www.ircwash.org/resources/united-nations-synthesis-report-arsenic-drinking-water

10 

S Maeda Arsenic in the Environment199415587

11 

R W Whitacre C S Pearse Arsenic and the EnvironmentMiner Industries Bull19721

12 

J T Hindmarsh R F McCurdy Clinical and environmental aspects of arsenic toxicityCrit Rev Clin Lab Sci19852343154710.3109/10408368609167122

13 

S M Nagvi C Vaishnavi H Singh Toxicity and metabolism of arsenic in vertebrates219945591

14 

T W Clarkson Inorganic and organometal pesticides199154552

15 

A Giberson Hemodialysis of acute arsenic intoxication with transient renal failureArch Intern Med19761361113034

16 

R E Gerhardt Chronic renal insufficiency from cortical necrosis induced by arsenic poisoningArch Intern Med1978138812679

17 

C H Rich M L Biggs A H Smith Lung and kidney cancer mortality associated with arsenic in drinking water in Cordoba, ArgentinaIntJ Epidemiol1998274561910.1093/ije/27.4.561

18 

S J S Flor Arsenic-induced oxidative stress and its reversibilityFree Radic Biol Med20115122578110.1016/j.freeradbiomed.2011.04.008

19 

IARC: Some drinking-water disinfectants and contaminants, including arsenicIARC Monogr Eval Carcinog Risks Hum2004841477

21 

J F Reichard M Schnekenburger A Puga Long term low-dose arsenic exposure induces loss of DNA methylationBiochem Biophys Res Commun200735211889210.1016/j.bbrc.2006.11.001

22 

W R Byron G W Bierbower J B Brouwer W H Hanse Pathological changes in rates and dogs from two year feeding of sodium arsenite or sodium arsenateToxicol Appl Pharmacol19671011324710.1016/0041-008x(67)90135-4

23 

A R Parrish X H Zheng K D Turney H S Younis A J Gandolfi Enhanced transcription factor DNA binding and gene expression induced by arsenite or arsenate in renal slicesToxicol Sci1999505019810510.1093/toxsci/50.1.98

24 

A Sasaki Y Oshima A Fujimura An approach to elucidate potential mechanism of renal toxicity of arsenic trioxideExp Hematol20073522526210.1016/j.exphem.2006.10.004

25 

A Kimura Y Ishida T Hayashi T Wada H Yokoyama T Sugaya Interferongamma plays protective roles in sodium arsenite induced renal injury by upregulating intrarenal multidrug resistanceassociated protein 1 expressionAm J Pathol2006169169411184610.2353/ajpath.2006.060024

26 

G Concha G Vogler D Lezcano B Nermell M Vahter Exposure to inorganic arsenic metabolites during early human developmentToxicol Sci19984421859010.1006/toxs.1998.2486

27 

G Lugo G Cassady P Palmisano Acute maternal arsenic intoxication with neonatal deathAm J Dis Children196911733283010.1001/archpedi.1969.02100030330015

28 

G L Dekundt A Leonard J Arany G J Dubuisson E Delavignetta In vivo studies in male mice on the mutagenesis effects of inorganic arsenicMutagenesis19861133910.1093/mutage/1.1.33

29 

S S Pinto C M Mcgill Arsenic trioxide exposure in industryInd Med Sura19532272817

30 

K C Saha Chronic arsenical dermatoses from tube-well water in West Bengal during 1983-87Indian J Dermatol1995401112

31 

V H Ferm D P Hanlon Constant rate exposure of pregnant hamsters to arsenate during early gestationEnviron Res198537242532

32 

A L Feldstein Arsenic and respiratory cancer in man: Follow-up of an occupational study1983104552

33 

S Wall Survival and mortality pattern among Swedish smelter workersInt J Epidemiol198091738710.1093/ije/9.1.73

34 

R Zaldivar Arsenic contamination of drinking water and foodstuffs causing endemic chronic arsenic poisoningBeitr Pathol1974151438440010.1016/s0005-8165(74)80047-8

35 

J S Fennel W K Stacy Electrocardiographic changes in acute arsenic poisoning. IrJ Med Sci198115011338910.1007/BF02938271

36 

S Goldsmith A H From Arsenic-induced atypical ventricular tachycardiaN Engl Med1986303191096710.1056/NEJM198011063031905

37 

W P Tseng Effect of dose-response relationships of skin cancer and Blackfoot disease withEnviron Health Perspect1977191091910.1289/ehp.7719109

38 

Environmental Protection Agency (EPA). Risk assessment Forum. Special Report on Ingested Inorganic Arsenic: Skin cancer, Nutritional Essentiality, Draft Report1988https://nepis.epa.gov/Exe/ZyNET.exe/300047B7.TXT?ZyActionD=ZyDocument&Client=EPA&Index=1986+Thru+1990&Docs=&Query=&Time=&EndTime=&SearchMethod

39 

K C Saha Chronic arsenical dermatoses from tube-well water in West Bengal during 1983-87Indian J Dermatol1995401112

40 

W L Schoolmeester D R White Arsenic poisoningSouth Med J198073198208

41 

J P Buchet R Lauwerys H Roels Comparison of the urinary excretion of arsenic metabolites after a single oral dose of sodium arsenite, monomethylarsonate, or dimethylarsinate in manInt Arch Occup Environ Health198148171910.1007/BF00405933

42 

G Mazumder D N Chakraborty A K Ghosh J Chakraborty D Gupta Chronic arsenic toxicity from drinking tube-well water in rural West BengalBull World Health Organ1988664499506

43 

M J Gonzalez M V Aguilar M C Martinez Mechanisms of absorption of As2O5 from rat small intestine: the effect of different parametersJ Trace Elem Med Biol1997112398610.1016/S0946-672X(97)80019-3

44 

S Silver T K Misra Bacterial Transformations of and Resistances to Heavy MetalsGenet Control Environ Pollutants1984282346

45 

R N Ratnaike A H Barbour Maldigestion and malabsorption200030217

46 

B Mandal K T Kumar Arsenic round the world: a reviewTalanta20025812012110.1016/S0039-9140(02)00268-0



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

Article type

Review Article


Article page

24-29


Authors Details

Shashi Pratap Singh, Shivam Sharma


Article History

Received : 19-01-2022

Accepted : 28-01-2022


Article Metrics


View Article As

 


Downlaod Files